Physician
Internal Medicine
Dr. Ivan O. Rosas, MD
|
|
Give Review
Dr. Ivan O. Rosas is an expert in the field of Internal Medicine. Ivan O. Rosas is also published. He has 34 publications published. The lastest publication: "Association Between Interstitial Lung Abnormalities and All-Cause Mortality.' He accepts all Medicare patients.
Publications
- Cryopreserved Human Precision-cut Lung Slices as a Bioassay for Live Tissue Banking: a Viability Study of Bronchodilation with Bitter-taste Receptor Agonists.
- Prevalence and outcome of Lung cancer in Lung transplant recipients.
- Detection of Rheumatoid Arthritis-Interstitial Lung Disease is Enhanced by Serum Biomarkers.
- Mechanosignaling through YAP and TAZ drives fibroblast activation and Fibrosis.
- Update in diffuse parenchymal Lung disease 2013.
- Radiation-Induced Impairment in Lung Lymphatic Vasculature.
- Transforming Growth Factor-β1 Downregulates Vascular Endothelial Growth Factor-D Expression in Human Lung Fibroblasts via JNK Signaling Pathway.
- Genetics and Early Detection in Idiopathic Pulmonary Fibrosis.
- Circulating mitochondrial DNA in patients in the ICU as a marker of mortality: derivation and validation.
- Tobacco Smoke-Induced Lung Fibrosis and Emphysema.
- Dysregulation of Galectin-3: Implications for Hermansky-Pudlak Syndrome Pulmonary Fibrosis.
- Syndecan-2 Exerts Antifibrotic Effects by Promoting Caveolin-1-mediated Transforming Growth Factor-β Receptor I Internalization and Inhibiting Transforming Growth Fact...
- Interstitial pneumonitis and the risk of Chronic allograft rejection in lung transplant recipients.
- MUC5B Promoter Polymorphism and Interstitial Lung Abnormalities.
- Identification of citrullinated heat shock protein 90 isoforms as novel autoantigens in rheumatoid arthritis-associated interstitial Lung disease.
- Matrix metalloproteinase-19 is a key regulator of Lung fibrosis in mice and humans.
- Subclinical interstitial Lung disease: why you should care.
- Automated Quantification of HRCT Findings in Individuals at Risk for Pulmonary Fibrosis.
- The HLA class II Allele DRB1*1501 is over-represented in patients with idiopathic Pulmonary fibrosis.
- Bleomycin and IL-1beta-mediated Pulmonary fibrosis is IL-17A dependent.
- Identification of early interstitial Lung disease in smokers from the COPDGene Study.
- Characterization and peripheral blood biomarker assessment of anti-Jo-1 antibody-positive interstitial Lung disease.
- Abnormal lymphangiogenesis in idiopathic Pulmonary fibrosis with insights into cellular and molecular mechanisms.
- MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic Pulmonary fibrosis.
- Progressive preclinical interstitial Lung disease in rheumatoid arthritis.
- Early interstitial lung disease in familial Pulmonary fibrosis.
- Impairment of alveolar macrophage transcription in idiopathic Pulmonary fibrosis.
- When it comes to genes--IPF or NSIP, familial or sporadic--they're all the same.
- Gene expression profiling as a window into idiopathic Pulmonary fibrosis pathogenesis: can we identify the right target genes?
- A comparison of visual and quantitative methods to identify interstitial Lung abnormalities.
- Epithelial Cell Mitochondrial Dysfunction and PINK1 Are Induced by Transforming Growth Factor- Beta1 in Pulmonary Fibrosis.
- Mononuclear Phagocytes and Airway Epithelial Cells: Novel Sources of Matrix Metalloproteinase-8 (MMP-8) in Patients with Idiopathic Pulmonary Fibrosis.
- Association Between Interstitial Lung Abnormalities and All-Cause Mortality.
Procedures Preformed
- Bronchoscopy
- Thoracentesis
- Ventilation Management
Conditions Treated
- Acute Pharyngitis
- Asthma
- Bronchiolitis
- Bronchitis
- View All
Doctors Specialties
- Critical Care Medicine
- Pulmonology
- Internal Medicine
Accepted Insurances
Education
-
Jackson Memorial Hospital - Jackson Health System -
Brooklyn Hospital Center -
National University of Colombia
Hospital
-
Brigham and Women's Hospital
Drug Facts
| NPI NUMBER | 1427023852 | |
| NPPES Provider LastName | ROSAS | |
| NPPES Provider FirstName | IVAN | |
| NPPES Provider ZIPCode | 208141422 | |
| NPPES Provider State | MD | |
| Specialty Description | Pulmonary Disease | |
| Total Claim Count | 308.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1427023852 |
| Last Name Of The Provider | ROSAS |
| First Name Of The Provider | IVAN |
| View All |
Similar Doctors
|
|
Dr. Daniela Lamas, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Michael J. Hensley
This Doctor is OpenDoctor Recommended.
|
|
|
Tamara Y. Greaves, MB BS |
|
|
Dr. Kevin C. Dennehy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Frank C. Kuo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rachel K. Putman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Naimish R. Patel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jerry M. Felson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel P. Katzman, MD |
|
|
Dr. Gerald W. Smetana, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Diego F. Martinez-Vasquez, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Aaron R. Kirkpatrick, MD |